Cookie privacy notice

Annual Report 2020/21

To our shareholders

Letter to shareholders

Sonova has successfully navigated the challenges imposed by the COVID-19 pandemic and sustained positive momentum in the market recovery, achieving strong earnings growth and cash flow in the second half-year.

2602

CHF million

–6.8% in local currencies

Group sales were CHF 2,602 million, a decrease of 6.8% in local currencies and 10.8% in Swiss francs. After a steep decline in the first quarter, sales recovered, returning to growth in the second half-year.

EBITA

603

CHF million

+5.6 in local currencies

The adjusted Group EBITA reached CHF 603.0 million, up 5.6% in local currencies and but down 2.9% in Swiss francs. As reported, Group EBITA stood at CHF 663.3 million, up 30.5% in local currencies and 19.7% in Swiss francs.

Key figures

Sales
in CHF m

Sales by regions
in 2020/21 in %

Adjusted EBITA
in CHF m

Adjusted EPS
in CHF

Operating Free Cash Flow
in CHF m

Number of
employees

Feature Story

“It’s like having new ears!”

Charles Owens is a jazz musician – and he wears hearing aids from Sonova brand Phonak. The saxophone player, who is over 80, finds them crucial, not only for listening to music and communicating with the members of his band, but also to help him teach his students and stay fully focused when his nine-year-old grandson practices saxophone with him.